BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18550704)

  • 1. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.
    Tseng IC; Chou FP; Su SF; Oberst M; Madayiputhiya N; Lee MS; Wang JK; Sloane DE; Johnson M; Lin CY
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C423-31. PubMed ID: 18550704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation.
    Lai CH; Lai YJ; Chou FP; Chang HH; Tseng CC; Johnson MD; Wang JK; Lin CY
    PLoS One; 2016; 11(4):e0152904. PubMed ID: 27043831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
    Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
    Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells.
    Chou FP; Xu H; Lee MS; Chen YW; Richards OX; Swanson R; Olson ST; Johnson MD; Lin CY
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1093-103. PubMed ID: 21795523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.
    Szabo R; Netzel-Arnett S; Hobson JP; Antalis TM; Bugge TH
    Biochem J; 2005 Aug; 390(Pt 1):231-42. PubMed ID: 15853774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1.
    Xu H; Xu Z; Tseng IC; Chou FP; Chen YW; Wang JK; Johnson MD; Kataoka H; Lin CY
    Am J Physiol Cell Physiol; 2012 Jan; 302(2):C453-62. PubMed ID: 22031598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
    Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
    PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease.
    Oberst MD; Chen LY; Kiyomiya K; Williams CA; Lee MS; Johnson MD; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Aug; 289(2):C462-70. PubMed ID: 15800053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.
    Lee MS; Kiyomiya K; Benaud C; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Apr; 288(4):C932-41. PubMed ID: 15590895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
    Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
    J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
    Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
    J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
    Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
    Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
    Domoto T; Takino T; Guo L; Sato H
    Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin.
    Lee SP; Kao CY; Chang SC; Chiu YL; Chen YJ; Chen MG; Chang CC; Lin YW; Chiang CP; Wang JK; Lin CY; Johnson MD
    PLoS One; 2018; 13(2):e0192632. PubMed ID: 29438412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the regulation of the matriptase-prostasin proteolytic system.
    Holt-Danborg L; Skovbjerg S; Goderum KW; Nonboe AW; Stankevic E; Frost ÁK; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 Nov; 477(22):4349-4365. PubMed ID: 33094801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor-1.
    Yamashita F; Kaieda T; Shimomura T; Kawaguchi M; Lin CY; Johnson MD; Tanaka H; Kiwaki T; Fukushima T; Kataoka H
    FEBS J; 2022 Jun; 289(12):3422-3439. PubMed ID: 35020274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.